Intelligent, Aggressive Representation For The Injured And Disabled

Attorneys Gardberg & Kemmerly
Photo of attorneys Jonathan P. Gardberg and Colin Edward Kemmerly

Study on Malaria Drugs issued to US Troops – Results Expected In March

by | Mar 16, 2020 | Veterans Disability Benefits |

Mefloquine – also issued under the name Lariam – is an anti-malarial drug issued to thousands of U.S. troops who served overseas. The drug was issued to troops who were deploying to countries such as Afghanistan, Djibouti, and other countries throughout Africa. Sometimes they were prescribed in the Middle East, in places like Iraq.

The FDA approved the use of mefloquine for treating and preventing malaria in 1989. It was regularly issued until 2009, when the US Army issued a policy listing it as a last-choice malaria medication. By then, there were countless stories of severe side effects from the drug. In 2013, the FDC placed a “black box” warning on the drug saying that it can cause ongoing or permanent neurological and psychiatric conditions, including dizziness, loss of balance, tinnitus, anxiety, depression, paranoia, and hallucinations even after discontinuing use.

Veterans issued the drug have reported symptoms that include vivid dreams, insomnia, anxiety, depression, and “brain fog.” Others reported vertigo, ringing in the ears, and loss of balance. These symptoms are sometimes diagnosed as PTSD. Current regulations allow Veterans to file for service-connection for mefloquine poisoning, but each case is decided on a case-by-case basis.

The current study is looking at the relationship between mefloquine and long-term neurological effects, psychiatric effects, and the potential development of post-traumatic stress disorder. If a causal link is found, this could speed the process for service connection for impairments related to mefloquine poisoning. Results are expected in March.

A finding of a causal relationship between mefloquine and psychiatric and neurological impairments could open the doors for service-connected compensation benefits for thousands of veterans. If you believe that you have experienced permanent impairments secondary to use of mefloquine, contact our firm for a free consultation. You may reach us at 251-343-1111 or 800-332-1529. Making that one little call and having a representative can make a huge difference. Gardberg and Kemmerly has experienced Veterans’ Disability attorneys willing to help you claim the benefits you deserve.



RSS Feed